FATE
Price
$1.13
Change
-$0.00 (-0.00%)
Updated
Jul 16 closing price
Capitalization
129.54M
13 days until earnings call
ZNTL
Price
$1.39
Change
+$0.05 (+3.73%)
Updated
Jul 16 closing price
Capitalization
100.01M
21 days until earnings call
Interact to see
Advertisement

FATE vs ZNTL

Header iconFATE vs ZNTL Comparison
Open Charts FATE vs ZNTLBanner chart's image
Fate Therapeutics
Price$1.13
Change-$0.00 (-0.00%)
Volume$974.26K
Capitalization129.54M
Zentalis Pharmaceuticals
Price$1.39
Change+$0.05 (+3.73%)
Volume$646.1K
Capitalization100.01M
FATE vs ZNTL Comparison Chart in %
Loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FATE vs. ZNTL commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Hold and ZNTL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (FATE: $1.13 vs. ZNTL: $1.39)
Brand notoriety: FATE and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 54% vs. ZNTL: 60%
Market capitalization -- FATE: $129.54M vs. ZNTL: $100.01M
FATE [@Biotechnology] is valued at $129.54M. ZNTL’s [@Biotechnology] market capitalization is $100.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $300.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, both FATE and ZNTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 4 TA indicator(s) are bullish while ZNTL’s TA Score has 4 bullish TA indicator(s).

  • FATE’s TA Score: 4 bullish, 6 bearish.
  • ZNTL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ZNTL is a better buy in the short-term than FATE.

Price Growth

FATE (@Biotechnology) experienced а -1.74% price change this week, while ZNTL (@Biotechnology) price change was +6.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.56%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +39.21%.

Reported Earning Dates

FATE is expected to report earnings on Oct 30, 2025.

ZNTL is expected to report earnings on Nov 03, 2025.

Industries' Descriptions

@Biotechnology (+2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($130M) has a higher market cap than ZNTL($100M). FATE YTD gains are higher at: -31.515 vs. ZNTL (-54.125). FATE has higher annual earnings (EBITDA): -168.28M vs. ZNTL (-199.29M). ZNTL has more cash in the bank: 332M vs. FATE (240M). ZNTL has less debt than FATE: ZNTL (38.7M) vs FATE (83.3M). ZNTL has higher revenues than FATE: ZNTL (26.9M) vs FATE (13.3M).
FATEZNTLFATE / ZNTL
Capitalization130M100M130%
EBITDA-168.28M-199.29M84%
Gain YTD-31.515-54.12558%
P/E RatioN/AN/A-
Revenue13.3M26.9M49%
Total Cash240M332M72%
Total Debt83.3M38.7M215%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FATEZNTL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 17 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMEGF107.420.40
+0.37%
Siemens Energy AG
ATTRF0.63N/A
N/A
Ascott Residence Trust
NSYC439.99N/A
N/A
National Stock Yards Co.
QCCUF0.07N/A
-5.45%
XXIX METAL CORP.
TAKOF0.56-0.05
-8.23%
VOLATUS AEROSPACE INC.